Genetic Signatures Ltd (GSS) — Capital Reinvestment Ratio

Latest as of June 2022: 1.32x

Genetic Signatures Ltd (GSS) has a Capital Reinvestment Ratio of 1.32x as of June 2022, meaning it reinvests 1% of its operating cash flow (AU$1.93 Million) in capital expenditures (AU$2.55 Million). Check Genetic Signatures Ltd (GSS) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.32x

Capex / Operating Cash Flow

Operating Cash Flow

AU$1.93 Million

AUD

Capital Expenditures

AU$2.55 Million

AUD

Data as of

Jun 2022

Most recent filing

Genetic Signatures Ltd Capital Reinvestment Ratio (2021–2022)

This chart tracks Genetic Signatures Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Genetic Signatures Ltd (GSS) cash conversion ratio.

Annual Capital Reinvestment Ratio for Genetic Signatures Ltd (2021–2022)

Year-by-year Capital Reinvestment Ratio for Genetic Signatures Ltd from 2021 to 2022. See free cash flow generation of Genetic Signatures Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2022	0.30x	AU$9.81 Million	AU$2.99 Million	▼ -74.3%
2021	1.19x	AU$4.20 Million	AU$4.98 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow